Presenilin-mediated cleavage of APP regulates synaptotagmin-7 and presynaptic plasticity.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30429473.
- Also identified by DOI 10.1038/s41467-018-06813-x and PMC identifier 6235831.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Mutations of the intramembrane protease presenilin (PS) or of its main substrate, the amyloid precursor protein (APP), cause early-onset form of Alzheimer disease. PS and APP interact with proteins of the neurotransmitter release machinery without identified functional consequences. Here we report that genetic deletion of PS markedly decreases the presynaptic levels of the Ca<sup>2+</sup> sensor synaptotagmin-7 (Syt7) leading to impaired synaptic facilitation and replenishment of synaptic vesicles. The regulation of Syt7 expression by PS occurs post-transcriptionally and depends on γ-secretase proteolytic activity. It requires the substrate APP as revealed by the combined genetic invalidation of APP and PS1, and in particular the APP-Cterminal fragments which interact with Syt7 and accumulate in synaptic terminals under pharmacological or genetic inhibition of γ-secretase. Thus, we uncover a role of PS in presynaptic mechanisms, through APP cleavage and regulation of Syt7, that highlights aberrant synaptic vesicle processing as a possible new pathway in AD.
Medical subject headings
- Alzheimer Disease
- Amyloid beta-Protein Precursor
- Neuronal Plasticity
- Presenilin-1
- Presenilin-2
- Synaptotagmins